Biosynthesized ZnO-NPs from Morus indica Attenuates Methylglyoxal-Induced Protein Glycation and RBC Damage: In-Vitro, In-Vivo and Molecular Docking Study.

Add to Collection

2019 Dec 16 Others S Anandan, M Mahadevamurthy, MA Ansari… - Biomolecules, 2019 - mdpi.com 49

Full Author : ['Anandan, Satish', 'Mahadevamurthy, Murali', 'Ansari, Mohammad Azam', 'Alzohairy, Mohammad A', 'Alomary, Mohammad N', 'Farha Siraj, Syeda', 'Halugudde Nagaraja, Sarjan', 'Chikkamadaiah, Mahendra', 'Thimappa Ramachandrappa, Lakshmeesha', 'Naguvanahalli Krishnappa, Hemanth Kumar', 'Ledesma, Ana E', 'Nagaraj, Amruthesh Kestur', 'Urooj, Asna']
Journal Title : Biomolecules
Chapter : Section3
Journal Year : 2019
Cited by : 26.0

The development of advanced glycation end-products (AGEs) inhibitors is considered to have therapeutic potential in diabetic complications inhibiting the loss of the biomolecular function. In the present study, zinc oxide nanoparticles (ZnO-NPs) were synt..... Read More

Keywords : ["morus indica attenuate methylglyoxalinduce protein glycation", "rbc damage invitro invivo", "molecular docking study", "biosynthesize znonps"]
PubMed Link : https://www.mdpi.com/597146
Google Scholar Link : https://scholar.google.com/scholar?cites=1903826843429314662&as_sdt=80005&sciodt=0,11&hl=en&num=20

Have a Question?

Biosynthesized ZnO-NPs from Morus indica Attenuates Methylglyoxal-Induced Protein Glycation and RBC Damage: In-Vitro, In-Vivo and Molecular Docking Study.